Cancer associated autoantibodies in idiopathic inflammatory myopathies: A retrospective cohort from a single center in China

Objectives: Idiopathic inflammatory myopathies (IIMs) are systemic, heterogeneous diseases, which mainly affect skeletal muscle. Myositis with cancer is often referred to as cancer-associated myositis (CAM), which is associated with poor prognosis. This study aimed to determine the cancer associated myositis-specific autoantibodies (MSAs) and to elucidate their associations with clinical features in Chinese patients with IIMs.Methods: This retrospective study enrolled 312 patients with IIMs who were treated at Tianjin Medical University General Hospital, China, from January 2015 to December 2020. Clinical data were collected. Serum MSAs, including anti-Mi-2, anti-TIF1--y, anti-NXP2, anti-SAE, anti-MDA5, anti-SRP, anti-Jo-1, anti PL-7, anti-PL-12, anti-OJ, anti-EJ and anti-HMGCR antibodies were detected. Cancer-associated MSAs, their phenotypic and survival features were estimated through SPSS 20.0.Results: The results revealed that anti-TIF1--y antibody and anti-SAE antibody were cancer-associated autoantibodies with odds ratios (95% CI) of 8.70 (3.35-22.64) and 22.31 (4.32-115.05), respectively. Skin lesions, proximal weakness, dysphagia and dysarthria were observed more frequently in patients carrying anti-TIF1--y antibody. By contrast, patients with anti-TIF1--y antibody had a lower frequencies of fever, arthritis/arthralgia and interstitial lung disease (ILD). Anti-TIF1--y antibody positive CAM comprised about half of CAM entities and had the characteristic of close temporal association with cancer detection/recurrence. Female-dominant, common reproductive system tumors were other clinical features of this subset. Besides, patients with anti-TIF1--y antibody positive had significantly lower survival rates than the anti-TIF1--y antibody negative group.Conclusions: Anti-TIF1--y antibody and anti-SAE antibody were cancer-associated autoantibodies. AntiTIF1--y antibody positive CAM was a subset that comprised about half of CAM entities and had the characteristic of poor prognosis.(c) 2022 Published by Elsevier Espan tilde a, S.L.U.